BAX and pachyonychia congenita: DAPT increased RIP and decreased Bcl-XL basal levels in MiaPaCa-2 tumorspheres (Figure 7F) and decreased the effects of leptin on Bax and Bcl-XL in 5-FU treated PC tumorspheres (Figure 7E and 7F).